Sarah B. Goldberg

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Scott Gettinger, Amit Mahajan et al. · The Lancet Oncology · 2016 · 987 citations · Full text

Neuro-oncology, Non-small-cell Lung Cancer, Untreated Brain Metastases +8

Expression of bacterial genes in plant cells.

R.T. Fraley, Stephen G. Rogers, R. Horsch et al. · Proceedings of the National Academy of Sciences · 1983 · 843 citations · Full text

Engineering, Chimeric Genes, Bacteriology +18

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Scott Gettinger, Jungmin Choi, Katherine Hastings et al. · Cancer Discovery · 2017 · 722 citations · Full text

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer

Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth et al. · JAMA Oncology · 2020 · 616 citations · Full text

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

Scott Antonia, Sarah B. Goldberg, Ani Sarkis Balmanoukian et al. · The Lancet Oncology · 2016 · 589 citations · Full text

Phase 1B, Medicine, Immunology +7